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ABSTRACT
Objectives To determine whether informed consent
introduces selection bias in prospective observational
studies using data from medical records, and consent
rates for such studies.
Design Systematic review.
Data sources Embase, Medline, and the Cochrane Library
up to March 2008, reference lists from pertinent articles,
and searches of electronic citations.
Study selection Prospective observational studies
reporting characteristics of participants and non-
participantsapproachedforinformedconsenttousetheir
medical records. Studies were selected independently in
duplicate; a third reviewer resolved disagreements.
Data extraction Age, sex, race, education, income, or
health status of participants and non-participants, the
participation rate in each study, and susceptibility of
these calculations to threats of selection and reporting
bias.
ResultsOf1650citations17uniquestudiesmetinclusion
criteria and had analysable data. Across all outcomes
there were differences between participants and non-
participants; however, there was a lack of consistency in
the direction and the magnitude of effect. Of 161604
eligible patients, 66.9% consented to use of data from
their medical records.
Conclusions Significant differences between participants
and non-participants may threaten the validity of results
fromobservationalstudiesthatrequireconsentforuseof
data from medical records. To ensure that legislation on
privacy does not unduly bias observational studies using
medical records, thoughtful decision making by research
ethics boards on the need for mandatory consent is
necessary.
INTRODUCTION
Informationfromreviewofmedicalchartsisoftenused
to carry out audits, perform non-interventional obser-
vational studies, create disease registries, and do other
types of health services research. Informed consent is
notalwaysnecessaryforthesetypesofresearch,which
involve abstraction of data from patients’ records.
Many such studies do not influence practice or
patients’ outcomes and therefore confer no risk and
nobenefittoparticipants.Thatnotwithstanding,recent
legislation to protect the privacy and confidentiality of
patients’informationinmedicalresearchintroducedin
many jurisdictions (for example, the regulations to the
HealthInsurancePortabilityandAccountabilityActin
the United States) has resulted in increased requests
fromresearchethicsboardstoobtaininformedconsent
tousedatafrommedicalrecordsforsuchobservational
studies.
1 As early as 1977 concerns were voiced about
t h ep o s s i b l en e g a t i v ei m p a c to fp r i v a c yl a w so n
epidemiological research.
2 More recently, editorial
reviews highlighted the negative impact of mandatory
informed consent on observational research through
conservative interpretation of privacy legislation.
3-5
As with many other aspects of research, require-
ments for informed consent to use data from medical
records vary across research ethics boards within and
among countries. For example, in a multisite study
involving a review of children’s charts who presented
to emergency departments with bronchiolitis, 34
research ethics boards arrived at divergent require-
ments for consent at their institutions, ranging from
nonetomandatorywrittenconsent.
6Fouroftheinvited
34 sites did not participate owing to the investigator
perceived hurdles with research ethics boards pertain-
ing to informed consent.
Ofgreaterconcernistheimpactofinformedconsent
onthe validityof the researchin observational studies,
audits, or registries. Mandatory informed consent in
suchnoriskorlowriskstudiescancreatechallengesto
implementationandbiasedresults.Forexample,inthe
Canadian Stroke Registry, investigators identified
important differences between participants and non-
participants in prognostic characteristics.
w1 The selec-
tion bias introduced by informed consent was suffi-
ciently serious to jeopardise the overall validity of the
study, and investigators effectively shut down the
registrybydiscontinuingfollow-upsurveysandrecord
linkagestudies.
w1Furthermore,casestudiesdocument-
ing the challenges of implementing informed consent
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of recruitment.
w1 w2
The primary objective of our systematic review was
to determine whetherinformed consentfor use of data
from medical records introduces selection bias by
examining differences in key personal characteristics
between participants and non-participants in prospec-
tive observational studies requiring informed consent
foraccesstomedicalrecords.Oursecondaryobjective
was to determine the rates of consent in these studies.
METHODS
We sought all studies reporting characteristics of
participants and non-participants approached for
informed consent to use data from their medical
records for prospective observational studies or
registries. We included studies reporting at least one
of the following characteristics: age, sex, race, educa-
tion,income,orhealthstatus.Wealsoincludedstudies
that requested consent for access to medical records in
additiontoselfadministeredorinterviewadministered
surveys or biological samples. However, we excluded
studies of interventions (for example, randomised
controlled trials) and studies using self administered
or interviewer administered surveys or biological
samples (for example, biobanks) alone. Owing to
limitations on resources, we included only English
language studies.
Afterconsultationwithalibrarianinhealthsciences,
we searched Embase (1980 to week 13 2008), Medline
(1966 to March week 3 2008), and the Cochrane
Library (Issue 1, 2008) (see web extra appendix A for
full search strategy). To identify further articles from
each included study, we searched reference lists, used
the PubMed “related articles” feature, carried out a
searchofcitedreferencesinThompsonScientific(Web
of Science), and used the Google Scholar “cited by”
feature.
Independently and in duplicate (MEK, MD) we
scannedcitationsfirstby title andthenby abstract.We
reviewed full reports of all potentially relevant
abstracts and calculated inter-rater reliability for
included studies using the κ statistic. We subsequently
resolved all disagreements through consensus; an
independent adjudicator (MCB) resolved outstanding
disagreements. Study population and setting, disease
status, and recruitment methods were extracted.
We calculated the participation rate in each study
7
and assessed the susceptibility of calculations on
participation rate against threats of selection and
reporting bias.
8 For each study we determined the
number of eligible participants, number approached
for consent, number who responded to the request for
consent, number of active consents, and number of
active declines.
Heterogeneity among the studies in study design,
recruitment methods, requests for consent, popula-
tions enrolled, and research settings precluded quanti-
tativesynthesisofthedata.
910WeusedRevManv4.2.8
(Cochrane Collaboration) to calculate odds ratios
(binary data), weighted mean differences (continuous
data), and 95% confidence intervals. We used the χ
2
statistic for comparisons of nominal data (>2
categories)
11 using SPSS version 16.0.
RESULTS
The electronic search identified 1650 citations, of
which 128 were duplicates and 1335 were excluded
afterreviewofthetitleorabstract.Of187publications
reviewed in full, 24 representing 23 unique studies
met the eligibility criteria.
w1-w24 The inter-rater relia-
bility for included studies was 0.84 (95% confidence
interval 0.83 to 0.86). Of the 23 eligible studies, 17
reported sufficient information for analyses of parti-
cipantsandnon-participantsandformthebasisofthis
review.
w1 w2 w4 w5 w7 w8 w10-w13 w15 w16 w18-w21 w23 w24 The
figure outlines the flow of included studies
12 and
table 1 summarises the characteristics of the studies.
Participation rates and susceptibility to bias
All 17 studies described eligibility criteria. Three
disclosed no information on how investigators identi-
fiedeligibleparticipantsforinformedconsent.
w15 w19 w23
Four approached all eligible participants and two
randomly selected eligible participants.
w12 w21 In five
studies, investigators were prevented from approach-
ing all potentially eligible participants owing to
physician approval,
w1 w2 w5 patient availability,
w1 and
study specific barriers.
w13 All but one study presented
sufficient information to reconstruct the outcomes of
participation (table 1).
w15
Of161604eligiblepatientsinthe17studies,108033
(66.9%, 95% confidence interval 66.6% to 67.1%)
provided active consent for use of data from their
Identified citations from Medline and Embase search (n=1650 )
Potentially relevant citations (n=1522)
Full publications assessed (n=187)
Duplicate citations (n=128)
Excluded studies (n=1336):
  Not relevant (n=980)
 Consent other than medical records (n=237)
 Studies of attitudes or interventions to improve
    informed consent (n=112)
 Retrospective study using medical records (n=7)
Insufficient information to compare
participants with non-participants (n=6) 
Eligible studies (n=24)
Included unique studies* (n=17)
Excluded studies (n=163):
 Not relevant (n=98)
 Consent other than medical records (n=60)
 Studies of attitudes or interventions to improve
    informed consent (n=3)
 Retrospective study using medical records (n=2)
Flow diagram of included studies. *Two separate publications
reported different outcomes from same study
w18 w19
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varied across the studies (from 36.6%
w21 to 92.9%
w20)
and approximated a normal distribution (not shown).
Table 2 outlines the methodological information
related to obtaining consent and table 3 outlines the
rates of participation in each study.
Differences between participants and non-participants
Authorsrepresentedthecharacteristicsofparticipantsand
non-participants in four different ways: continuous data,
w1 w2 w8 w11 w21 proportions,
w1 w2 w4 w5 w7 w10 w11 w19 w21 w23 w24
regression analyses,
w13 and the weighted proportion
ofpatientsdecliningconsentafteradjustmentforstudy
design.
w12 w20 Studies reported comparisons between
participants and non-participants with different
denominators: four studies reported consent of
those eligible,
w1 w2 w16 w23 eight of those approached,
w4 w7 w8 w12 w19-w21 w24 and four of those who responded.
w5 w10 w13 w15 One study reported the denominator for
consent on the basis of the availability of personal
Table 1 |Characteristics of included studies
Study Setting Eligible participants Recruitment methods Authorisation request
Reported
outcomes
Bryant 2006
w4 Cohort study, Canada English speaking adults aged
between 35 and 69 with no known
history of cancer, residing in Alberta
Random digit dialling and interview
byresearchteam,recruitmentperiod
October 2000 to June 2002
Request for periodic data linkages with
Alberta cancer registry and data on
utilisation of health services
Age, sex
Buckley2007
w5 Cohort study, Ireland;
multicentre (n=35)
Adults with established ischaemic
heart disease
Postal survey from researchers,
recruitment period not stated
(follow-up of CoHeart Study)
Request for access to medical records,
survey
Age, sex, income,
health status
Dunn 2004
w7 Cohort study, UK;
multicentre (1-5 centres,
depending on study)
Adults meeting eligibility criteria for
six different studies
Postal survey (senders unspecified),
recruitment period August 1996 to
June 2002
Separate requests for access to medical
records and future contact
Age, sex
Edlund 1985
w8 Cohort study, USA; single
centre
Adult inpatients with tardive
dyskinesia
Personal contact in hospital
(recruiters unspecified), recruitment
period not reported
Request for access to medical records Age
Harris 2004
w10 Cohort study, UK; two
centres
Adults aged more than 65 from two
London practices
Postal survey (senders unspecified),
recruitment period not stated
Separate requests for access to medical
records, survey or questionnaire
Age, sex, race,
income, health
status
Huang 2007
w11 Cohort study, Taiwan Adults aged 20 or more from 2001
Taiwanese National Health Interview
Survey with valid identification
number
Personal contact by researchers,
recruitment period not reported
Request for access to national health
insurance records
Age, sex, race,
income,
education, health
status
Jacobsen
1999
w12
Registry, USA; single centre Adult outpatients receiving medical
care at Mayo Clinic, Rochester, MN
Postal survey from researchers,
recruitment period January to April
1997
Request for access to medical records Age, sex, health
status (Charlson
comorbidity)
Klassen 2005;
NICU and
healthy
children
w13
Cohort study, Canada; two
centres
Children born between 1996 and
1997 in two British Columbia
hospitals and three NICUs
Postal survey from researchers,
recruitment period not stated
NICU and healthy children; separate
requests for access to medical records
(mother and baby), survey
Maternal age,
sex, income
Matsui 2005;
non-genetic
and genetic
w15
Cohort study, Japan;
Takashima study
Adults from geographical
catchments in four Japanese areas
attending annual health check up
Personal contact by researchers,
physicians and nurses, recruitment
period 2002-3
Non-genetic: two catchments, separate
requests for access to medical records,
survey, blood sample; genetic: two
catchments, same as for non-genetic plus
genetic analysis, DNA analysis
Sex
McKinney
2005
w16
Registry, England;
multicentre (n=5)
Children admitted to PICU Personal contact by PICU staff,
recruitment period May to July 2003
Request for access to medical records Age, sex, race,
income, health
status
Schwartz
2005
w19;
Phipps2004
w18
Registry, USA; three centres Adults with stroke or traumatic brain
injury from 1 of 3 rehabilitation
service systems in south eastern
Pennsylvania
Personal contact at clinic by “site
recruiters”, recruitment period not
specified
Separate requests for medical records and
future contact
Age, sex, race
Tate 2006
w20 Cohort study, UK;
Millennium cohort
Children born between September
2000 and January 2002
Personal contact, recruitment period
not stated
Request for access to medical records
(mother and baby)
Maternal age,
race, income,
education
Tu 2004;
phases I and
II
w1
Registry, Canada;
multicentre (n=20),
Canadian Stroke Registry
Network
Adults with acute stroke, transient
ischaemic attacks, or both
Personal contact in hospital by
research nurses, two recruitment
phases:June2001toFebruary2002,
June 2002 to December 2002
Separate requests for access to medical
records,futurecontact,interview,releaseof
aggregate data to commercial organisation
Age, sex, race
Woolf 2000
w21 Registry, USA; single centre Adults in primary care for practice
based research network
Personal contact by clinic
administrativestaff,recruitmentMay
to November 1999
Combined request for access to medical
records and future contact
Age, sex, race,
income,
education, health
status
Yawn 1998
w23 Registry, USA; single centre Adult and paediatric attendees at
medical centre
Personal contact and postal survey
(emergency department patients) by
administrative clinic staff,
recruitment period January to
February 1997
Request for access to medical records Age, sex
Young 2001
w24 Cohort study, Australia;
Australian Longitudinal
Study on Women’sH e a l t h
Women participating in Australian
Longitudinal Study on Women’s
Health
Postal survey from researchers,
recruitment period March 1997
Request for access to medical records Age, education
NICU=neonatal intensive care unit; PICU=paediatric intensive care unit.
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 3 of 8characteristics.
w11 We describe comparisons between
participantsandnon-participantsaccordingtoage,sex,
race, income, education, and health status. Table 4
summarises differences by these outcomes.
Age—Sixteen studies reported characteristics of the
participantsandnon-participantsbyage(seewebextra
appendix B1).
w1 w2 w4 w5 w7 w8 w10-w13 w16 w19-w21 w23 w24
Seven studies found no age related differences,
w2 w5 w8
w10 w13 w16 w21 one found that participants were younger
than non-participants,
w19 and seven identified signifi-
cant differences across age strata; however, no clear
pattern emerged.
w4 w7 w11 w12 w20 w23 w24 In the Canadian
StrokeRegistry Network,participantsin phase Iof the
study were younger than non-participants, whereas in
phase II there were no differences
w1 after a change in
recruitment strategy.
Sex—Fourteen studies that recruited both males and
femalesreportedthecharacteristicsofparticipantsand
non-participants by sex (see web extra appendix
B2).
w1 w2 w4 w5 w7 w10-w13 w15 w16 w19 w21 w23 Six studies
reported no differences in the odds of females
participating compared with males.
w2 w10 w12 w13 w16 w23
In the six studies where there were differences, two
determined that females were more likely to consent
than males,
w4 w7 whereas four determined that females
werelesslikelytoconsentthanmales.
w5 w11 w19 w21Inthe
remaining two studies the participation of females
differed between subgroups. In the Takashima cohort
study there was no difference in the likelihood of
participation between females and males enrolled in a
group requesting access to their medical records in
addition to surveys and a blood sample. However,
females were less likely to participate than males with
the addition of genetic testing to the request for access
to medical records, surveys, and a blood sample.
w15
The Canadian Stroke Registry Network initially had
nodifferencesinparticipationratesbetweenthesexes;
after a change in recruitment strategy fewer females
than males participated.
w1
Race—Six studies reported the characteristics of
participants and non-participants by race (see web
extra appendix B3).
w1 w10 w11 w18 w20 w21 Two found no
difference in the odds of obtaining consent by race.
w10
w18Threestudiesdeterminedhigherparticipationrates
inwhiteorCaucasianpatientsthanothers,
w1 w20 w21and
aTaiwanesestudyofnationalhealthrecordsidentified
differences across four strata of race.
w11
Income—Seven publications reported participants
and non-participants by income (see web extra
appendix B4).
w5 w10 w11 w13 w16 w20 w21 Four studies found
nodifferencesbyincome.
w5 w10 w16 w21Acrossfivestrata
of income, Huang et al
w11 identified varying rates of
participation for access to Taiwanese National Health
Insurance records. Another study reported no
Table 2 |Methodological elements to describe informed consent
Study
Element
Didinvestigatorsdescribe
how eligible people were
identified?
Were eligible people equally
likely to be approached to
participate?
If eligible people were not equally likely to be
approached to participate, how were people chosen
for participation?
Did investigators report
consent related outcomes
for all eligible people?
Al-Shahi 2005
w2 Yes No Approvalbygeneralpractitionerorhospitalconsultant Yes
Bryant 2006
w4 Yes Yes NA Yes
Buckley
w5 Yes No Contact by general practitioner Yes
Dunn 2004
w7 Yes Yes NA Yes
Edlund 1985
w8 Yes Yes NA Yes
Harris 2004
w10 Yes No Approval by general practitioner or district nurses, no
dementia, alive and living in practice area; on the
electoral register and had contact with the practice
within the last 5 years*
Yes
Huang 2007
w11 Yes Yes NA Yes
Jacobsen 1999
w12 Yes Yes Random selection Yes
Klassen 2005; healthy children
w13 Yes No Ability to contact, English language, vital status of
mother or baby
Yes
Klassen 2005; NICU
w13 Yes No Ability to contact, English language, vital status of
mother or baby
Yes
Matsui; genetic 2005
w15 Yes No Not stated No
Matsui; non-genetic 2005
w15 Yes No Not stated No
McKinney 2005
w16 Yes No Not stated Yes
Schwartz 2005
w19 Yes No Not stated No
Tate 2006
w20 Yes Yes NA Yes
Tu 2004; phase I
w1 Yes No Doctor approval, patient availability Yes
Tu 2004; phase II
w1 Yes No Doctor approval, patient availability Yes
Woolf 2000
w21 Yes Yes Random selection Yes
Yawn 1998
w23 Yes No Not stated Yes
Young 2001
w24 Yes Yes NA Yes
NICU=neonatal intensive care unit; NA=not available. Criteria informed by Guyatt and Rennie.
8
*Reasons for exclusion reported in Harris et al.
13
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intensive care units, whereas there were differences
across income categories in parents of healthy
babies.
w13 Women who never worked or who were
unemployedlongtermwerelesslikelytoparticipatein
the UK millennium cohort study; however, after
adjusting for education, socioeconomic status did not
independently predict participation.
w20
Education—Six studies reported participants and
non-participantsbyeducation(seewebextraappendix
B5).
w11 w13 w19-w21 w24 Two studies found no differences
related to education
w13 w21; however, in the Australian
LongitudinalStudyonWomen’sHealth,thosewomen
who had continued their education beyond school
were more likely to participate. Three studies that
described participants and non-participants by strata
identified significant differences, although no clear
patterns emerged.
w11 w19 w20
Health status—All six studies that reported health
status found differences between participants and non-
participants(seeweb extraappendix B6).
w2 w10-w12 w16 w21
In two studies participants had more disability or
comorbidity than non-participants as measured by the
Charlson comorbidity index
w12 and the physical com-
ponents summary.
w21 Two studies reported that parti-
cipants had less disability than non-participants as
measuredbythemodifiedRankinscore
w2anddisability
score.
w10 One study reported higher SF-36 subscale
scores in physical function, role physical, vitality, and
general health in participants and no differences in role
emotional, social functioning, bodily pain, and mental
health.
w11 In a study that enrolled patients from the
paediatric intensive care unit, participation varied by
strata for risk of death.
w16
DISCUSSION
Biasresultsinsystematicdeviationfromtheunderlying
truth.
8Jacobsenetalusedthetermauthorisationbiasto
describe statistically significant differences between
participants and non-participants in research that used
medical records.
w12 In this systematic review we
identified 17 unique studies comparing participants
and non-participants in observational studies that
requested access to medical records. Across all out-
comesthereweredifferencesbetweenparticipantsand
non-participants, although there was a lack of consis-
tencyinthedirectionandthemagnitudeofeffect.Thus
although results of this systematic review suggest that
requirements for informed consent introduced a
varietyofbiasesintoprospectiveobservationalstudies
using data from medical records, no systematic
deviations occurred and the cause of the differences
by age, sex, race, income, education, or health status
thatdidemergeisunclear.Moststudiesdidnotexplore
Table 3 |Participation rates by study and associated participation rates
Study Eligible Approached Responded Active consent Active decline No response
Not
approached
Participation
rate (%)
Al-Shahi 2005
w2 187 131 111 111 0 20 56 59.4
Bryant 2006
w4 11 865* 11 865 11 865 11 525 338 0 0 97.1
Buckley 2007
w5 1383† 1269 876 574 302 393 114 41.5
Dunn 2004
w7 33 101 33 101 22 644 18 172 4472 11 239 0 53.6
Edlund 1985
w8 93 93 93 40 53 0 0 43.0
Harris 2004
w10 2843‡ 2276 1704 1565 139 572 567§ 55.0
Huang 2007
w11 15 413¶ 15 413 15 413 13 504** 1909 0 0 87.6
Jacobsen 1999
w12 2463 2463 2023 1941†† 82 440†† 07 8 . 8
Klassen 2005; healthy children
w13 691 592 393 274 119 199 126 38.2
Klassen 2005; NICU
w13 2098 1692 1140 832 308 552 529 37.5
Matsui; genetic 2005
w15 2195 NR 2195 1855 340‡‡ 84.5
Matsui; non-genetic 2005
w15 3166 NR 3166 2900 266‡‡ 91.6
McKinney 2005
w16 422 183 183 182 1 0 239 43.1
Schwartz 2005
w19 2422 2164 1817 1256 563 346 258 51.9
Tate 2006
w20 18 505 18 505 17 221 17 195 26 1284 0 92.9
Tu 2004; phase I
w1 4825 2078 2078 1684 394 0 2207§§ 39.3
Tu 2004; phase II
w1 2823 1761 1761 1428 333 0 1062§§ 50.6
Woolf 2000
w21 1229 1106 1021 743 278 85 123 36.3
Yawn 1998
w23 15 997 15 789 15 069 14 493 576 720 208 90.6
Young 2001
w24 39 883 39 883 20 864 19 700 1164 19 019 0 49.3
NR-not reported.
*Includes two transgendered people for whom consent information was not available.
†Authors reported 1609 eligible; we adjusted this number to 1383 after excluding 226 from the original cohort who were dead at the time of the follow-up study and not eligible for inclusion.
‡Number eligible reported in Harris et al.
13
§Reasons for not being approached reported in Harris et al.
13
¶802 of 15 413 eligible people did not complete all parts of demographic survey and were not included in demographic analyses.
**Includes 593 people who consented to access of data from medical records but did not complete all parts of demographic survey.
††Per authors, non-respondents were considered as positive consent per Minnesota law. Table includes those who actively consented.
‡‡Aggregate data reported.
§§Not approached because of language barrier, surrogate decision maker unavailable and other, and patients died or left hospital.
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patients. This is an important gap, as failure to ask for
consent may indicate deficiencies in organisational
planning that call for a different policy response than
does refusal to participate. At this stage the state of the
research is such that our ability to predict these
differences with confidence and to guide researchers
to avoid authorisation bias is limited.
In terms of our secondary objective, participation
rates varied substantially. Studies with high participa-
tion rates showed selection biases, the proportion of
eligibleparticipantsapproachedforenrolmentdiffered
across studies and we identified opportunities to
improve the reporting of outcomes for consent.
Whereas all studies reported how investigators identi-
fied eligible people, four did not report how those
eligible were chosen for participation.
w 1 5w 1 6w 1 9w 2 3
Knowing such information helps us to better interpret
howsusceptiblethesefourstudiesweretoselectionbias
before the introduction of informed consent.
Our review indicates that consent rates for studies
using medical records vary considerably, affecting
recruitment efforts and potentially influencing study
results. Accordingly, consideration of these factors in
Table 4 |Summary of differences between participants and non-participants by study
Study
Personal characteristics
Age Sex Race Income Education Health status
Al-Shahi 2005
w2 NS NS NR NS NR Less disability
(Rankin score); P<0.001
Bryant 2006
w4 Varied by age strata;
P<0.001
More females:
odds ratio 2.21
(95% CI 1.77 to 2.75)
NR NR NR NR
Buckley 2007
w5 NS Fewer females:
odds ratio 0.73
(95% CI 0.54 to 0.97)
NR NS NR NR
Dunn 2004
w7 Varied by age strata;
P<0.001
More females:
odds ratio 1.07
(95% CI 1.03 to 1.12)
NR NR NR NR
Edlund 1985
w8 NS NR NR NR NR NR
Harris 2004
w10 NS NS NS NS NR More disability
(disability score);
P<0.001
Huang 2007
w11 Varied by age strata;
P<0.001
Fewer females:
odds ratio 0.90
(95% CI 0.81 to 1.0)
Varied by race strata;
P<0.001
Varied by income
strata; P<0.001
Varied by education
strata; P<0.001
VariedbySF-36subscale
Jacobsen 1999
w12 Varied by age strata;
P<0.001
NS NR NR NR More comorbidity
(Charlson index ≥2);
P=0.008
Klassen 2005; healthy
w13 NS NS NR Variedby income strata NS NR
Klassen 2005; NICU
w13 NS NS NR NS NS NR
Matsui; genetic 2005
w15 NR NS NR NR NR NR
Matsui; non-genetic 2005
w15 NR Fewer females:
odds ratio 0.62
(95% CI 0.46 to 0.82)
NR NR NR NR
McKinney 2005
w16 NS NS NS NS NR Varied by paediatric risk
of mortality score;
P=0.024
Schwartz 2005
w19 and Phipps
2004
w18 (race)
Younger: 58.7 (20.2) v
67.7 (18.6)
Fewer females:
odds ratio 0.67
(95% CI 0.49 to 0.91)
NS NR Varied by education
strata; P=0.019
NR
Tate 2006
w20 Varied by age strata NR Varied by race strata Variedby income strata Varied by education
strata
NR
Tu 2004; phase I
w1 Younger; 69 v 72,
P<0.001
NS Varied by race strata;
P<0.001
NR NR NR
Tu 2004; phase II
w1 NS Fewer females:
odds ratio 0.79
(95% CI 0.68 to 0.91)
Varied by race strata;
P<0.001
NR NR NR
Woolf 2000
w21 NS Fewer females:
odds ratio 0.59
(95% CI 0.42 to 0.81)
Fewer black patients;
P=0.013
NS NS More physical disability;
weighted mean
difference −2.5
(95% CI −3.98 to −1.02)
Yawn 1998
w23 Varied by age strata;
P=0.018
NS NR NR NR NR
Young 2001
w24 Varied by age strata;
P<0.001
NR NR NR Moreeducationbeyond
school level; P<0.001
NR
NR=not reported; NS=no statistically significant difference between participants and non-participants. See web extra appendix B for detailed information on each characteristic.
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Willison et al offered practical advice forstudies based
on consent at local and systems levels after their
experiences of involving multisites in the Canadian
Stroke Registry Network, such as testing the consent
process by using a pilot, close communication with
research ethics boards and healthcare institutions,
consideration of random sampling strategies, and
ongoingmonitoringandfeedbackonaccrual.
14Recent
recommendations reinforce the explicit reporting of
personal comparisons between participants and non-
participants as an important feature of publications on
observational studies.
15 Future research needs to
systematically study why otherwise eligible patients
are not approached for consent and the characteristics
of patients associated with refusal to participate in
studies using medical records.
Pragmatically what should researchers planning a
prospective observational study that involves medical
records do? The United Kingdom National Health
Service Act 2006 (Section 251),
16 the common rule of
the Health Insurance Portability and Accountability
Act,
17 and the Canadian Institutes for Health
Research
18 offer guidance to researchers on informed
consent for research involving medical records.
Although consent is required for the collection of
personal information from participants for medical
procedures, medical examinations, and clinical trials,
exemptionfromrequiringconsentmaybeappropriate
for studies using medical records owing to impractic-
ability of informed consent and the possibility of
introducing biased study results.
18
We suggest requesting a waiver of consent from the
research ethics board for research using medical
records because these studies confer no or minimal
risk, do not directly benefit the patient, and because of
the potential biases introduced through loss of data in
ways that are not completely at random. We suggest
explicitly outlining the procedures the research team
will take to protect the privacy and confidentiality of
each patient. For example, to minimise the risks of a
breach of confidentiality, researchers could collect the
minimum personal information necessary for identifi-
cation from each record and incorporate strict access
policies to the data at patient level.
However, if a waiver of consent is not possible, as in
some European Union jurisdictions,
19 we suggest
collecting a minimum dataset of key prognostic
variables on all eligible people for the study identified
throughscreening.Thesedatacanbeusedtocarryout
a preliminary analysis comparing participants with
non-participants on the key prognostic variables at
predetermined times during study accrual, taking into
accountstatisticaladjustmentsformultiplesignificance
t e s t i n g .S u c ha na p p r o a c hm a yl e a dt or e v i s e d
recruitment strategies to address these concerns—for
example, tailored recruitment, targeting participation
of populations less likely to grant consent.
Onthebasisoffindingsfromthisreview,thevalidity
of results from observational studies that require
consent for access to medical records may be
threatenedasaresultofsignificantdifferencesbetween
participants and non-participants. Across the conti-
nuum of research we suggest three strategies to
minimise the impact of authorisation bias at the
inception, reporting, and interpretation of research.
Atinceptionwesuggestwidespreadeducationaimedat
clinicians, researchers, and research ethics boards on
the conditions under which studies can proceed
without individual consent. To help us better interpret
differences between participants and non-participants
we suggest standardised reporting of methods used to
seek informed consent. We believe the elements we
reportintable2providetheminimumdatasetforthese
purposes and could serve as the foundation for
expectations on quality reporting. Similarly, we
advocate standardised key metrics on informed con-
sent such as participation rates, including eligible,
approached, responded, active consent, and active
declines (see table 3). Finally, in interpreting observa-
tional studies that exhibit significant differences
between participants and non-participants, clinicians
and researchers should be aware of differences in
important prognostic variables and their possible
impact on study results. The box summarises our
recommendedstrategiestominimisetheimpactofbias
from informed consent.
Strengths and limitations of the study
Our review has several strengths. A priori we devel-
oped comprehensive search strategies with librarians
in health sciences who were familiar with the indexing
methods of electronic databases on health. We
included both Medline and Embase, which are
complementary bibliographic databases of the biome-
dical literature
20; we supplemented included articles
with searches of cited references and related articles.
Weusedbroadsearchstrategiesofpublishedliterature
Five suggested strategies to minimise the impact of bias
from informed consent
Request a waiver of consent from research ethics boards
and explicitly outline procedures to protect the privacy
and confidentiality of each patient
If a waiver is not possible then:
Collectaminimumdatasetofkeyprognosticvariables
on all eligible people identified through screening
Complete a preliminary analysis comparing
participants and non-participants on key prognostic
variables at predetermined times
Revise the strategy for recruitment as necessary
Aim education at clinicians, researchers, and research
ethics boards on conditions under which studies can
proceed without individual consent
Standardise reporting of methods used to seek informed
consent
Increase awareness by clinicians and researchers of the
potentialimpactofselectionbiasintroducedbyinformed
consent and implications for interpretation of the study
RESEARCH
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parent reporting.
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Ourreviewalsohaslimitations.Oursearchincluded
only studies in English available in the peer review
literature.Becauseofthevariabilityinresultswedonot
expect exclusion of non-English studies to impair the
generalisability of our findings; however, this hypoth-
esis needs to be confirmed in future research. Our
review was limited by the published reports, including
lack of clarity about the sample size and reporting
standards for screening and consent procedures. Not
all studies reported data on our outcomes of interest;
authorsmaynothavecollecteddataontheseoutcomes
or chose to report only significant differences between
participants and non-participants.
w7 w20 w24 For exam-
ple,ofthetwostudiesreportingallsixofouroutcomes
of interest, one identified statistically significant
differences by sex, race, and health status and no
differences by age, income, or education,
w21 whereas
theotherstudyidentifiedsignificantdifferencesbyage,
race, income, education, and health status and no
differences by sex.
w11 Because these observational
studies were not specifically designed to study differ-
ences in consent between participants and non-
participants, we may have observed statistically
significant differences across our outcomes of interest
simply by chance.
8
Conclusion
In conclusion, we observed authorisation bias in
studies requiring informed consent for use of data
from medical records. To assess better the impact of
informed consent on prospective observational stu-
dies, consistent reporting of core personal factors of
known prognostic significance between the character-
istics of participants and non-participants is necessary.
To ensure that legislation on privacy does not unduly
threatenthevalidityofobservationalstudiesusingdata
from medical records, educationof bodies responsible
for overseeing research and further investigations are
urgently needed on the determinants and conse-
quences of consent and non-consent for these studies.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Privacy legislation has resulted in some research ethics
boards requiring informed consent to use medical records
Whethermandatoryinformedconsentcreatesselectionbias
in these observational studies is unknown
WHAT THIS STUDY ADDS
Of 1650 citations, 17 unique studies met inclusion criteria
andhadanalysabledataonthefollowingsixoutcomes:age,
sex, race, education, income, or health status
Across all outcomes, differences between participants and
non-participants occurred, although there was a lack of
consistency in the direction and the magnitude of effect
To ensure that legislation does not unduly bias
observational studies using medical records, thoughtful
decision making by research ethics boards on the need for
mandatory consent is necessary
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